Study protocol of the LARK (TROG 17.03) clinical trial: a phase II trial investigating the dosimetric impact of Liver Ablative Radiotherapy using Kilovoltage intrafraction monitoring

BACKGROUND: Stereotactic Ablative Body Radiotherapy (SABR) is a non-invasive treatment which allows delivery of an ablative radiation dose with high accuracy and precision. SABR is an established treatment for both primary and secondary liver malignancies, and technological advances have improved it...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:BMC Cancer
Hoofdauteurs: Lee, Yoo Young Dominique, Nguyen, Doan Trang, Moodie, Trevor, O’Brien, Ricky, McMaster, Anne, Hickey, Andrew, Pritchard, Nicole, Poulsen, Per, Tabaksblat, Elizaveta Mitkina, Weber, Britta, Worm, Esben, Pryor, David, Chu, Julie, Hardcastle, Nicholas, Booth, Jeremy, Gebski, Val, Wang, Tim, Keall, Paul
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BioMed Central 2021
Onderwerpen:
Study Protocol
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8091536/
https://ncbi.nlm.nih.gov/pubmed/33941111
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-021-08184-x
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items